Dr. Ami Sanghvi: Resolving the case of MODY 3
Complex clinical cases not only provide a learning opportunity but also bring along immense satisfaction. Dr. Ami Sanghvi created a positive difference in the...
Author: MHD Team
Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
In order to stratify the risk of having Heart failure with preserved ejection fraction (HFpEF) in patients with dyspnea, two scoring systems namely H2FPEF...
Pharmacological Heart Failure Treatment and its association with Outcomes of Postponement of Death
Introduction • Heart failure (HF) is a serious condition and prevalent in 1-2% adults, with high mortality rates (~ 50%) within 5 years of...
Algorithm to choose optimal β-Blocker in patients with Heart Failure
Introduction β-blockers are effective in the treatment of heart failure (HF) and have shown to improve clinical outcomes. However, HF patients with respiratory comorbidities...
Updates on Pharmacokinetic Profile of β‐blockers
Introduction Beta-blockers (β-blockers) are associated with intra-class variability including differences in their pharmacokinetic profile. Determination of intra-class pharmacokinetic as well as pharmacodynamic variability of...
β-blockers in elderly patients with CHF and CKD: What is the impact on mortality?
In this article, we present to you data from a large retrospective cohort study that investigated the impact on mortality with β-blockers use versus...
